Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

NobelParallel CC TiUltra RP 5.0 x7mm: medical device reports filed with FDA

1,460 reports name it, 2020–2026. Manufacturer given most often on reports: Nobel Biocare. Product code DZE.

1,460
device reports naming the brand
0% of all MAUDE reports · about 258 a year
404
reports, 12 months to August 2026
347 in the 12 months before
0.9%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 1,460 reports that name the brand "NobelParallel CC TiUltra RP 5.0 x7mm" (endosseous dental implant), received between November 2020 and August 2026; the manufacturer given most often on reports is Nobel Biocare. Spellings of one product vary from report to report.

404 reports arrived in the 12 months to August 2026, up 16% from 347 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (99.1%) and malfunction (0.9%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (64.1%), loss of osseointegration (22.7%) and osseointegration problem (7%). The patient problems coded most often are failure of implant, pain and appropriate clinical signs, symptoms and conditions term/code not available. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

04488Sep 2021: 8Oct 2021: 10Nov 2021: 14Dec 2021: 132022Jan 2022: 16Feb 2022: 10Mar 2022: 12Apr 2022: 10May 2022: 10Jun 2022: 8Jul 2022: 24Aug 2022: 2Sep 2022: 12Oct 2022: 20Nov 2022: 16Dec 2022: 122023Jan 2023: 10Feb 2023: 10Mar 2023: 22Apr 2023: 16May 2023: 10Jun 2023: 28Jul 2023: 26Aug 2023: 18Sep 2023: 26Oct 2023: 12Nov 2023: 28Dec 2023: 182024Jan 2024: 22Feb 2024: 24Mar 2024: 26Apr 2024: 42May 2024: 20Jun 2024: 30Jul 2024: 32Aug 2024: 18Sep 2024: 42Oct 2024: 26Nov 2024: 28Dec 2024: 342025Jan 2025: 34Feb 2025: 24Mar 2025: 42Apr 2025: 6May 2025: 0Jun 2025: 1Jul 2025: 88Aug 2025: 22Sep 2025: 46Oct 2025: 28Nov 2025: 34Dec 2025: 342026Jan 2026: 22Feb 2026: 32Mar 2026: 54Apr 2026: 58May 2026: 26Jun 2026: 24Jul 2026: 24Aug 2026: 22

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

01803592020: 620202021: 11320212022: 15220222023: 22420232024: 34420242025: 35920252026: 2622026

Event type and report source

Event type, as classified on the report

Death0%0
Injury99.1%1,447
Malfunction0.9%13
Other0%0
Not given0%0

Who filed the report

Manufacturer report49.9%729
Voluntary report0%0
User facility report0%0
Distributor report50.1%731
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate93664.1%62.8%
Loss of osseointegration33222.7%22.4%
Osseointegration problem1027%7.7%
Patient device interaction problem181.2%0.3%
Migrationthe device moved from where it was placed141%0.1%
Fracturea broken bone80.5%1.6%
Premature separation60.4%0.1%
Activation, positioning or separation problem40.3%0%
Difficult to insertthe device was hard to insert40.3%0.4%
Insufficient device problem information40.3%0.2%
Difficult to removethe device was hard to remove20.1%0%
Malposition of device20.1%0.1%
Mechanical problema mechanical problem20.1%0.1%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Failure of implant90962.3%
Painpain, site not specified886%
Appropriate clinical signs, symptoms and conditions term/code not available281.9%
Numbnessnumbness241.6%
Implant pain221.5%
Inflammationinflammation201.4%
Sinus perforation120.8%
Abscessa collection of pus60.4%
Bone fracture(s)60.4%
Foreign body in patientpart of a device left in the patient60.4%
Fistula40.3%
Discomfortdiscomfort20.1%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureNobelParallel CC TiUltra RP 5.0 x7mmProduct code DZEAll MAUDE reports
Reports1,4603,924,24126,136,888
Share of that pool—0%0%
Classified as death, per 1,000 reports009
Classified as injury99.1%99.2%36.2%
Classified as malfunction0.9%0.8%62.3%
Filed by the manufacturer49.9%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about NobelParallel CC TiUltra RP 5.0 x7mm reports

How many FDA reports name NobelParallel CC TiUltra RP 5.0 x7mm?

1,460 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 404 in the latest 12 months.

What kinds of events are reported?

injury (99.1%) and malfunction (0.9%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (64.1%), loss of osseointegration (22.7%), osseointegration problem (7%), patient device interaction problem (1.2%) and migration (1%). These are FDA's device problem codes as entered on the report.

Who files these reports?

distributor reports (50.1%) and manufacturer reports (49.9%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that NobelParallel CC TiUltra RP 5.0 x7mm was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.